Jennifer Petrie

BSc (Hons) University of Glasgow

School of Medicine and Population Health

Trial Manager

j.petrie@sheffield.ac.uk
+44 114 222 0676
+44 114 273 0870 (Fax)
Barber House

Full contact details

Jennifer Petrie
School of Medicine and Population Health
Barber House
Sheffield
S10 2HQ
Profile

I joined the ±¬ÁÏTV in June 2016 having previously worked as a Trial Manager at the MRC Clinical Trials Unit at UCL where I was involved in the management of a number of large phase III CTIMP trials.

Within CTRU, I ​currently work as a Trial Manager on the E​XPERTS-ALS Trial. ​EXPERTS-ALS is a multicentre, Bayesian phase II randomised drug prioritisation platform. It  is designed to accelerate progress towards highly-effective drug therapies for amyotrophic lateral sclerosis (ALS, the commonest form of motor neurone disease, MND)​.  The study will screen candidate drugs in those living with ALS, more quickly identifying those with signals of likely clinical benefit, that may then be prioritised for testing in larger placebo-controlled trials.

Research interests
  • Controlled clinical trials
  • Clinical trials methodology

Current projects:

  • OPTION-DM (Optimal Pathway for TreatIng neuropathic paiN in Diabetes Mellitus)
  • STAR MS: Autologous stem cell transplantation versus alemtuzumab or ocrelizumab in relapsing remitting multiple sclerosis
Publications

Journal articles

  • Petrie J, Loban A, Turton E, Derebecka J, North S, Herbert E & Hind D (2024) . Contemporary Clinical Trials, 142.
  • Brittain G, Petrie J, Duffy KEM, Glover R, Hullock K, Papaioannou D, Roldan E, Beecher C, Bursnall M, Ciccarelli O , Coles AJ et al (2024) . BMJ Open, 14(2).
  • Marincowitz C, Stone T, Bath P, Campbell R, Turner JK, Hasan M, Pilbery R, Thomas BD, Sutton L, Bell F , Biggs K et al (2024) . BMJ Quality and Safety, 33(6).
  • Brittain G, Coles AJ, Giovannoni G, Muraro PA, Palace J, Petrie J, Roldan E, Scolding NJ, Snowden JA & Sharrack B (2023) . Practical Neurology, 23(2), 139-145.
  • Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Young T, Rajbhandari S, Sharma S, Rayman G, Gouni R , Alam U et al (2022) . Health Technology Assessment, 26(39).
  • Hasan M, Bath PA, Marincowitz C, Sutton L, Pilbery R, Hopfgartner F, Mazumdar S, Campbell R, Stone T, Thomas B , Bell F et al (2022) . Computers in Biology and Medicine, 151, Part A.
  • Tesfaye S, Sloan G, Petrie J, White D, Bradburn M, Julious S, Rajbhandari S, Sharma S, Rayman G, Gouni R , Alam U et al (2022) . The Lancet, 400(10353), 680-690.
  • Sharrack B, Petrie J, Coles A & Snowden JA (2022) . British Medical Journal, 377.
  • Marincowitz C, Stone T, Hasan M, Campbell R, Bath PA, Turner J, Pilbery R, Thomas BD, Sutton L, Bell F , Biggs K et al (2022) . BMJ Open, 12(5).
  • Marincowitz C, Sutton L, Stone T, Pilbery R, Campbell R, Thomas B, Turner J, Bath PA, Bell F, Biggs K , Hasan M et al (2022) . Emergency Medicine Journal, 39, 317-324.
  • Selvarajah D, Petrie J, White D, Julious S, Bortolami O, Cooper C, Bradburn M, Loban A, Bowler H, Swaby L , Sutherland K et al (2018) . Trials, 19.
  • Bielicki J, Sharland M, Lyttle M, Hartshorn S & Petrie J (2016) . Emergency Medicine Journal, 33(12), 933.3-934.

Preprints

  • Marincowitz C, Stone T, Hasan M, Campbell R, Bath PA, Turner J, Pilbery R, Thomas B, Sutton L, Bell F , Biggs K et al (2021) , Cold Spring Harbor Laboratory.
  • Marincowitz C, Stone T, Bath P, Campbell R, Turner J, Hussein M, Pilbery R, Thomas B, Sutton L, Bell F , Biggs K et al (2021) , Cold Spring Harbor Laboratory.
  • Hasan M, Bath P, Marincowitz C, Sutton L, Pilbery R, Hopfgartner F, Mazumdar S, Campbell R, Stone T, Benjamin T , Bell F et al () .

Links

CTRU